skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.12d (Release date: 2017-12-26)
SearchBox Top
SearchBox Bottom
Alefacept (Code C65220)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Alefacept

Definition: A recombinant dimeric fusion protein consisting of the extracellular CD2-binding domain of the human leukocyte function-associated antigen 3 (LFA-3; CD58) linked to the Fc portion of human immunoglobulin G1 (IgG1) with potential immunosuppressive activity. Alefacept binds to the CD2 receptor expressed on the majority of T lymphocytes, blocking the binding of endogenous LFA-3, located on antigen-presenting cells (APCs), to the CD2 receptor; the activation and proliferation of T lymphocytes in response to LFA-3 binding is thus inhibited. In addition, binding of the IgG1 moiety of this agent to the Fc gamma receptor on the surface of natural killer (NK)cells may bridge NK cells and target T lymphocytes, initiating NK cell-mediated apoptosis of T lymphocytes.

NCI-GLOSS Definition: A drug that is used to treat certain skin conditions and is being studied in the treatment of cutaneous (skin-related) T-cell cancer and T-cell non-Hodgkin lymphoma. Alefacept is made by combining part of an antibody with a protein that blocks the growth some types of T cells. It is a type of fusion protein and a type of immunosuppressant.

Display Name: Alefacept

Label: Alefacept

NCI Thesaurus Code: C65220 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C0962603  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)

External Source Codes: 
CAS Registry Number 222535-22-0 (see NLM ChemIDplus info)
PDQ Closed Trial Search ID 531798
PDQ Open Trial Search ID 531798 (check for NCI PDQ open clinical trial info)
UMLS CUI C0962603

Other Properties:
     Name Value (qualifiers indented underneath)
code C65220
Contributing_Source CTRP
Contributing_Source FDA
Legacy_Concept_Name Alefacept
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom